Omnichannel in MENA: Follow the Doctor, Not the Channel
Why MENA pharma teams must build around HCP behaviour and orchestration, not channel inventories, and the three moves that matter over the next 24 months.
Behavior Before Channels
The most common omnichannel failure in the region is starting from a channel inventory instead of a behavior map. Teams ask whether to add a WhatsApp journey before asking what the cardiologist in Jeddah or the GP in Alexandria actually does when a new molecule enters their consideration set. Channels are cheap to list and expensive to orchestrate; behavior is the only reliable basis for deciding which ones deserve investment.
In our work across the region we consistently see a few behavioral patterns worth building around:
- Peer validation happens in closed messaging groups before it appears in any public forum, so share worthy assets matter more than portal logins.
- Language use is situational: scientific content is consumed in English, while trust building and peer discussion happen in Arabic or mixed language.
- Congress season creates sharp attention spikes, and engagement drops steeply when follow up does not arrive within days.
- Messaging apps dominate in North Africa, while Gulf markets remain more responsive to email and formal digital touchpoints.
A behavior map like this reframes the strategy conversation. The question stops being which channels the brand owns and becomes at which behavioral moments the brand can be genuinely useful. That is a smaller and far more answerable list, and it usually cuts channel spend rather than adding to it.
The Orchestration Gap
Omnichannel is not the sum of channels; it is the sequencing logic between them, and that logic is where MENA teams are weakest. A doctor who attends a webinar, receives an unrelated rep visit two days later, and then gets a generic email a week after that has been touched by three channels and has experienced zero orchestration. The value sits entirely in the connective tissue: what happened last should shape what happens next.
Orchestration in this region has to accommodate three constraints. CRM data quality is uneven, so sequencing rules must degrade gracefully when the last interaction is unknown. Field teams retain real autonomy, so orchestration works better as decision support for reps than as rigid automation imposed on them. And regulatory expectations differ by market, so a journey designed for the UAE cannot be copied into Saudi Arabia or Egypt without local review.
Teams that treat these as design inputs ship working journeys. Teams that wait for perfect data ship decks. The difference is rarely budget; it is whether anyone owns the journey end to end.
Measuring Momentum, Not Activity
Channel level metrics describe activity; orchestration metrics describe momentum, and only the second kind tells a brand whether its omnichannel model is actually working. Opens, visit counts, and webinar attendance can all rise while the HCP experience remains fragmented and forgettable.
The metrics that matter are relational: time between touches, the share of HCPs receiving a coherent sequence versus random contacts, and progression through a defined engagement ladder. In our work across the region we consistently see that affiliates reporting this second set have a strategy, while affiliates reporting only the first set have a calendar.
The Next Twenty Four Months
The affiliates pulling ahead in MENA share a recognizable operating pattern: one owner for the HCP experience across field and digital, journeys built per specialty rather than per brand template, and Arabic treated as core infrastructure rather than translation at the end. None of this requires exotic technology. It requires accountability for the whole journey instead of a channel.
Three moves matter most in the near term. Consolidate identity, so there is one view of each HCP across rep, event, and digital touchpoints, even if imperfect. Build messaging first, assuming the doctor is on a phone between patients rather than at a desktop. Localize sequencing as well as content, because the right next touch after a congress in Riyadh differs from the right next touch after a webinar in Cairo.
The window is real but closing. HCP attention in MENA is still winnable at reasonable cost compared to saturated Western markets, yet the same demographic and digital forces that created the opportunity are compressing it. The companies that learn to follow behavior now will own the engagement patterns everyone else spends the next decade trying to buy back.
The rep visit did not lose its power in MENA. It lost its monopoly.